These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33163558)

  • 1. Myoclonus and COVID-19: A Challenge for the Present, a Lesson for the Future.
    Latorre A; Rothwell JC
    Mov Disord Clin Pract; 2020 Nov; 7(8):888-890. PubMed ID: 33163558
    [No Abstract]   [Full Text] [Related]  

  • 2. The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity.
    Welsh JP; Placantonakis DG; Warsetsky SI; Marquez RG; Bernstein L; Aicher SA
    Adv Neurol; 2002; 89():307-29. PubMed ID: 11968457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine exacerbates myoclonic jerks in a rat model of posthypoxic myoclonus.
    Tai KK; Truong DD
    Brain Res; 2010 Jul; 1343():194-8. PubMed ID: 20434435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaphragmatic myoclonus due to SARS-CoV-2 infection.
    Borroni B; Gazzina S; Dono F; Mazzoleni V; Liberini P; Carrarini C; Russo M; Pontolillo M; Vecchiet J; Onofrj M; Bonanni L
    Neurol Sci; 2020 Dec; 41(12):3471-3474. PubMed ID: 33090303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated generalized myoclonus immune-mediated by SARS-CoV-2: an illustrative videotaped case.
    El Otmani H; Moutaouakil F; Ouazzani M; Mjahed K
    Neurol Sci; 2021 Aug; 42(8):3411-3413. PubMed ID: 33718991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.
    Przytuła F; Błądek S; Sławek J
    Neurol Neurochir Pol; 2021; 55(3):310-313. PubMed ID: 34096013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists.
    Pappert EJ; Goetz CG; Vu TQ; Ling ZD; Leurgans S; Raman R; Carvey PM
    Neurology; 1999 Jan; 52(1):16-21. PubMed ID: 9921842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal model of posthypoxic myoclonus: II. Neurochemical, pathologic, and pharmacologic characterization.
    Kanthasamy AG; Nguyen BQ; Truong DD
    Mov Disord; 2000; 15 Suppl 1():31-8. PubMed ID: 10755270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relief of intractable posthypoxic myoclonus after administration of agomelatine.
    González de la Aleja J; Saiz-Díaz RA; De la Peña P
    Clin Neuropharmacol; 2012; 35(5):258-9. PubMed ID: 22986800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole exacerbates posthypoxic action myoclonus in a patient with suspicion of Pneumocystis jiroveci infection.
    Jundt F; Lempert T; Dörken B; Pezzutto A
    Infection; 2004 Jun; 32(3):176-8. PubMed ID: 15188079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome.
    Wiegand SE; Mitchell WG; Santoro JD
    Mult Scler Relat Disord; 2021 May; 50():102855. PubMed ID: 33677410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between brain indole levels and severity of posthypoxic myoclonus in rats.
    Matsumoto RR; Aziz N; Truong DD
    Pharmacol Biochem Behav; 1995 Apr; 50(4):533-8. PubMed ID: 7542390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glutamate receptor antagonists on posthypoxic myoclonus in rats.
    Jaw SP; Vuong QT; Nguyen M
    Brain Res Bull; 1996; 40(3):163-6. PubMed ID: 8736576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short "Infraslow" Activity (SISA) With Burst Suppression in Acute Anoxic Encephalopathy: A Rare, Specific Ominous Sign With Acute Posthypoxic Myoclonus or Acute Symptomatic Seizures.
    Togo M; Hitomi T; Murai T; Yoshimura H; Matsuhashi M; Matsumoto R; Kawamoto M; Kohara N; Takahashi R; Ikeda A
    J Clin Neurophysiol; 2018 Nov; 35(6):496-503. PubMed ID: 30387784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.
    Chan JL; Murphy KA; Sarna JR
    J Neurol; 2021 Oct; 268(10):3517-3548. PubMed ID: 33616739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoclonus and Cerebellar Ataxia Associated with SARS-CoV-2 Infection: Case Report and Review of the Literature.
    Giannantoni NM; Rigamonti E; Rampolli FI; Grazioli-Gauthier L; Allali G; Vanini G
    Eur J Case Rep Intern Med; 2021; 8(5):002531. PubMed ID: 34123943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.
    Finsterer J; Scorza FA
    Neuroophthalmology; 2023; 47(1):1-6. PubMed ID: 36798867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology of human posthypoxic myoclonus.
    Hallett M
    Mov Disord; 2000; 15 Suppl 1():8-13. PubMed ID: 10755266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute cerebellar ataxia and myoclonus with or without opsoclonus: a para-infectious syndrome associated with COVID-19.
    Foucard C; San-Galli A; Tarrano C; Chaumont H; Lannuzel A; Roze E
    Eur J Neurol; 2021 Oct; 28(10):3533-3536. PubMed ID: 33492711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.